Journal article
Cécile Demarez, L. D. de Assis, M. Krohn, Nahuel A. Ramella, M. Schwaninger, H. Oster, M. Astiz
Development, 2021
Development, 2021
Semantic Scholar
DOI
PubMed
Cite
Cite
APA
Click to copy
Demarez, C., de Assis, L. D., Krohn, M., Ramella, N. A., Schwaninger, M., Oster, H., & Astiz, M. (2021). The trophoblast clock controls transport across placenta in mice. Development.
Chicago/Turabian
Click to copy
Demarez, Cécile, L. D. de Assis, M. Krohn, Nahuel A. Ramella, M. Schwaninger, H. Oster, and M. Astiz. “The Trophoblast Clock Controls Transport across Placenta in Mice.” Development (2021).
MLA
Click to copy
Demarez, Cécile, et al. “The Trophoblast Clock Controls Transport across Placenta in Mice.” Development, 2021.
BibTeX Click to copy
@article{c2021a,
title = {The trophoblast clock controls transport across placenta in mice.},
year = {2021},
journal = {Development},
author = {Demarez, Cécile and de Assis, L. D. and Krohn, M. and Ramella, Nahuel A. and Schwaninger, M. and Oster, H. and Astiz, M.}
}
Abstract
In mammals, 24-h rhythms of physiology and behavior are organized by a body-wide network of clock genes and proteins. Despite the well-known function of the adult circadian system, the roles of maternal, fetal and placental clocks during pregnancy are poorly defined. In the mature mouse placenta, the labyrinth zone (LZ) is of fetal origin and key for selective nutrient and waste exchange. Recently, clock gene expression has been detected in LZ and other fetal tissues; however, there is no evidence of a placental function controlled by the LZ clock. Here, we demonstrate that specifically the trophoblast layer of the LZ harbors an already functional clock by late gestation, able to regulate in a circadian manner the expression and activity of the xenobiotic efflux pump, ATP-binding cassette sub-family B member 1 (ABCB1), likely gating the fetal exposure to drugs from the maternal circulation to certain times of the day. As more than 300 endogenous and exogenous compounds are substrates of ABCB1, our results might have implications in choosing the maternal treatment time when aiming either maximal/minimal drug availability to the fetus/mother.
